Wegovy, Ozempic and Alcoholism

After easing diabetes and weight loss journey for many, the popular medications Ozempic and Wegovy have shown fresh promise ...
Meanwhile, Hims & Hers tackles the GLP-1 shortage with a new app; Eli Lilly releases data on tirzepatide efficacy; 23andMe faces privacy concerns; and more.
In an essay for 'Women's Health,' Dr. Nora Volkow discusses the future of semaglutide weight-loss meds, and their potential ...
Some GLP-1 receptor agonists may hold promise as treatments for alcohol use disorder (AUD), a Swedish observational study ...
It's something Downey says he has struggled with for years — addiction to both food and alcohol. The 39-year-old says he's sober now, and he believes Wegovy is helping him stay that way.